Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-019040
Filing Date
2018-01-25
Accepted
2018-01-25 07:49:56
Documents
21
Period of Report
2018-01-25

Document Format Files

Seq Description Document Type Size
1 6-K d528269d6k.htm 6-K 11161
2 EX-99.1 d528269dex991.htm EX-99.1 29666
3 EX-99.2 d528269dex992.htm EX-99.2 14840
4 GRAPHIC g528269ex99_2s10g1.jpg GRAPHIC 532933
5 GRAPHIC g528269ex99_2s11g1.jpg GRAPHIC 184128
6 GRAPHIC g528269ex99_2s12g1.jpg GRAPHIC 162528
7 GRAPHIC g528269ex99_2s13g1.jpg GRAPHIC 136215
8 GRAPHIC g528269ex99_2s14g1.jpg GRAPHIC 327570
9 GRAPHIC g528269ex99_2s15g1.jpg GRAPHIC 186549
10 GRAPHIC g528269ex99_2s16g1.jpg GRAPHIC 186960
11 GRAPHIC g528269ex99_2s17g1.jpg GRAPHIC 295962
12 GRAPHIC g528269ex99_2s1g1.jpg GRAPHIC 286221
13 GRAPHIC g528269ex99_2s2g1.jpg GRAPHIC 526546
14 GRAPHIC g528269ex99_2s3g1.jpg GRAPHIC 307797
15 GRAPHIC g528269ex99_2s4g1.jpg GRAPHIC 168280
16 GRAPHIC g528269ex99_2s5g1.jpg GRAPHIC 291632
17 GRAPHIC g528269ex99_2s6g1.jpg GRAPHIC 312720
18 GRAPHIC g528269ex99_2s7g1.jpg GRAPHIC 247405
19 GRAPHIC g528269ex99_2s8g1.jpg GRAPHIC 268435
20 GRAPHIC g528269ex99_2s9g1.jpg GRAPHIC 289098
21 GRAPHIC g528269img1.jpg GRAPHIC 11312
  Complete submission text file 0001193125-18-019040.txt   6562915
Mailing Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB
Business Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB 44-123-544-3939
Summit Therapeutics plc (Filer) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0114
Type: 6-K | Act: 34 | File No.: 001-36866 | Film No.: 18546645
SIC: 2834 Pharmaceutical Preparations